AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

Salmeterol Xinafoate Equivalent To Salmeterol

9 registrations across 1 African market— 9 active

Markets with Salmeterol Xinafoate Equivalent To Salmeterol

Recent registrations

Brand / ProductMarketHolderStatusExpires
DUOASMA DPI 50/100🇿🇦South AfricaGlenmark Pharmaceuticals South Africa (Pty) LtdactiveMar 2030
DUOASMA DPI 50/100🇿🇦South AfricaGlenmark Pharmaceuticals South Africa (Pty) LtdactiveMar 2030
DOUASMA DPI 50/250🇿🇦South AfricaGlenmark Pharmaceuticals South Africa (Pty) LtdactiveMar 2030
SALMETROL XINAFOATE/FLUTICASONE PROPIONATE 50/500 CIPLA🇿🇦South AfricaCipla Medpro (Pty) LtdactiveNov 2028
SEREFLO 50/500 DPI🇿🇦South AfricaCipla Medpro (Pty) LtdactiveNov 2028
SEREHALE 50/500🇿🇦South AfricaInnovata PharmaceuticalsactiveApr 2028
SEREHALE 50/250🇿🇦South AfricaInnovata PharmaceuticalsactiveApr 2028
SEREHALE 50/100🇿🇦South AfricaInnovata PharmaceuticalsactiveApr 2028
SEREVENT ACCUHALER🇿🇦South AfricaGlaxoSmithKline South Africa (Pty) LimitedactiveJan 1900

Salmeterol Xinafoate Equivalent To Salmeterol in Africa — Regulatory Overview

Salmeterol Xinafoate Equivalent To Salmeterol is registered across 1 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 9 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.